Home > Insider Trading > Filing (0001779453-20-000005)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662774	Cortexyme Inc.	CRTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1779451	Chad Boeding	One Lombard Street, Suite 200 San Francisco CA 94111		No	No	No	Yes
1779453	Epiq Capital Group, Llc	One Lombard Street, Suite 200 San Francisco CA 94111		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-11	6,600	$44.32	2,858,527	No	4	P	Indirect	By Mr. Boeding as Trustee of the Boeding Family Trust
Common Stock	Acquisiton	2020-06-12	2,440	$44.06	2,860,967	No	4	P	Indirect	By Mr. Boeding as Trustee of the Boeding Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Mr. Boeding as Trustee of the Boeding Family Trust
No	4	P	Indirect	By Mr. Boeding as Trustee of the Boeding Family Trust

Footnotes

The reporting persons are EPIQ Capital Group, LLC ("EPIQ") and Chad Boeding. EPIQ is the investment adviser and managing member of EPQ LLC, CTYM PS ("CTYM") and CTEPQ Partners LLC ("CTEPQ"). Together CTYM and CTEPQ beneficially own more than 10% of the common stock of the issuer. Mr. Boeding is the Manager of EPIQ. EPIQ is filing this Form 4 on behalf of itself and Mr. Boeding jointly, but not as a group. CTYM, CTEPQ and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.